PharmEnable Therapeutics Alternatives & Competitors
12 companies similar to PharmEnable Therapeutics — Harnessing the power of chemical novelty, diversity and 3-dimensionality to deve...
Cellcolabs
Cellcolabs mission is to prevent and cure diseases by making high quality stem cells avail...
Solna, Sweden
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics.
Somerville, United States
Basilard BioTech, Inc.
Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies
United States
ProFound Therapeutics
Pioneering the expanded human proteome to reveal a universe of new medicines.
Track all PharmEnable Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
Burlingame, United States
Diagen AI
Proprietary Gen AI for Drug Discovery, Diagnostics, Vaccine Development & Longevity
Canada
C3 | Clinical Consulting Consortium
C3 is a woman-owned niche CRO with an extensive network of highly experienced CRAs in vari...
Savannah, United States
Tentarix Biotherapeutics
Enabling Intelligent Therapies with Multifunctional Biologics
San Diego, United States
InduPro
Proximity by design
Seattle, United States
Ochre Bio
Oxford, United Kingdom
Panthera Biopartners
An independent SMO partner providing the right patient, for the right trial, at the right...
Preston, United Kingdom
ReNAgade Therapeutics
RNA Without Limits
Cambridge, United States
About PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs
AI-driven drug discovery, Development of small molecule drugs, Therapeutic target identification, Pipeline development
Pharmaceutical companies, Biotechnology firms, Medical researchers, Healthcare providers
AI-enabled Drug Discovery, Small Molecule Drugs, Chemical Novelty, 3D Chemical Space Exploration, Oncology Therapeutics, Neurology Therapeutics, Proprietary AI Platform, ChemSEEK, Antibody-like Specificity, Drug Discovery Partnerships, University Of Cambridge Spinoff, Inaccessible Disease Targets
B2B, Platform, B2B2B
Licensing, Service Fee, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches PharmEnable Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at PharmEnable Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 26 Jan 2026 and 24 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.